26.5 F
New York
Wednesday, November 29, 2023

FDA to make decisions on several drug applications in July (NASDAQ:BIIB)

Must read

Share Me


Headquarters of US Food and Drug Administration (FDA)


Several drugmakers are eagerly awaiting application decisions from the FDA in July.

The most significant decision comes on July 6, when Biogen (NASDAQ:BIIB) and Eisai (OTCPK:ESALF) will find out if the agency will convert accelerated approval for


Source link

- Advertisement -spot_img

More articles


Please enter your comment!
Please enter your name here

Latest article